Prevalence of hepatitis-B surface antigen among population of inmates in Tihar Jail, New Delhi

Shweta Rana, Narinder K. Girdhar, Manmeet K. Gill, Arun Kumar

Abstract


Background: Hepatitis B Virus (HBV), a DNA virus with a human only reservoir, is a worldwide public health problem. Unlike other countries especially Europe and America, there is scarcity of published data on HBV infection among prison inmates in India despite its tremendous importance in public heath formulation compared to the general population. The present study was designed to investigate the prevalence of Hepatitis B surface antigen among population of Jail inmates (convicts).

Methods:The study population comprised of all the 1102 prison inmates who were screened for Hepatitis B surface antigen (HBsAg) status using one step immunochromatographic array [INSTACHK Hepatitis-B]. Seroprevalence rate of seropositive was calculated and stratified by age and sex. The seropositives were further subjected to HBeAg and anti-HBe detection, HIV status, anti HCV status, HBV-DNA levels and Liver function tests (LFTs) and the patients were then classified into three groups based on HBV-DNA levels and alanine amino transferase (ALT) levels.

Results:Out of 1102 inmates screened, 30 (2.72%) were HBsAg positive. Slightly higher percentage prevalence of HBsAg was found among males i.e., 3.19% (or 27/844) than females i.e., 1.16% (or 3/258). Out of 30 HBsAg positive cases, 16 were HBeAg negative, 8 were HBeAg positive and 6 refused to get investigated further. Ten of the 16 HBeAg negative cases were further subjected to anti HBe detection. Half of these cases (5) were reactive for anti-HBe. Based on HBV DNA levels and ALT levels, 8 patients were categorized as HBeAg positive chronic hepatitis-B patients, 12 patients were categorized as HBeAg negative chronic Hepatitis-B patients and 4 patients as inactive HBsAg carriers.

Conclusion:HBsAg prevalence among Tihar Jail inmates is comparable to that among the non-incarcerated general population in India.

 


Keywords


Hepatitis B virus (HBV), Hepatitis B surface antigen (HBsAg), Seroprevalence, Seroconversion

Full Text:

PDF

References


Hwang EW, Cheung R. Global epidemiology of Hepatitis B virus (HBV) infection. NAJ Med Sci. 2011;4(1):7-13..

World Health Organization. Hepatitis B vaccines. Wkly. Epidemiol Record. 2009;40:405-20.

Lodha R, Jain Y, Anand K. Hepatitis B in India: a review of disease epidemiology. Indian Pediatr. 2001;38(4):349-71.

Behal R, Jain R, Behal KK, Bhagoliwal A, Aggarwal N. Dhole. Seroprevalence and risk factors for hepatitis-B virus infection among general population in Northern India. Arq Gastroenterol. 2008;45(2):137-40.

Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and Incidence of HIV, hepatitis-B virus and hepatitis-C virus infections among males in Rhode island Prisons. Am J Public Health. 2004;94(7):1218-23.

Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunodeficiency, virus, hepatitis-B virus and hepatitis-C virus: seroprevalence, co-infection and risk factors among prison inmates in Nasarawa State Nigeria. J Infect Dev Ctries. 2009;3(7):539-47.

Sobeslavsky O. Prevalence of markers of hepatitis-B virus infection in various countries: a WHO collaborative study. Bull World Health Organ. 1980;58(4):621-8.

Franco E, Bagnato B, Marino MG, Maleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):74-80.

Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346(22):1682-3.

Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol. 2007;13(1):14-21.

Kao JH, Wu NH, Chen PJ. Hepatitis B genotypes and the response to interferon therapy. J Hepatol. 2000;33(6):998-1102.

Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. National Med J India. 2006;19(4):203-17.

Choudhury A. Epidemiology of HBV infection in India. Hep B Annual. 2004;1:17-24.

John TJ, Abraham P. Hepatitis-B in India. A review of disease epidemiology. Indian Pediatr. 2001;38:1318-22.

Sonware BR, Buare SD, Kulkarni PV. Prevalence of seroactivity among blood donors in rural population. Indian J Med Sci. 2003;57(9):405-7.

Chandrasekaran S, Palaniappan N, Krishanan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis-B viral markers and hepatitis-C virus antibodies (Anti HCV) in Madurai, S. India. Indian J Med Sci. 2000;54(7):270-3.

Jain RC, Bhat SD, Sangle S. Prevalence of hepatitis surface antigen among rural population of Loni area in Ahmednagar district of Western Maharashtra. J Assoc Physicians India. 1992;40(6):390-1.

Satoskar A, Ray V. Prevalence of hepatitis-B surface antigen (HBsAg) in blood donors from Bombay. Trop Geogr Med. 1992;44(1):119-21.

Kurien T, Thyagarajan SP, Jeyaseelan L, Peedicayil A, Rajendran P, Sivaram S, et al. Community prevalence of hepatitis-B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res. 2005;121:670-5.

Joshi SH, Gorakshakar AC, Mukherjee M, Rao VR, Sathe MS, Aabhavane SM, et al. Prevalence of HBsAg carrier among some tribes of Madhya Pradesh. Indian J Med Res. 1990;91:340-3.

Jain RC. Prevalence of HBsAg among tribal population of Udaipur district in S. Rajasthan. Indian J Med Microbiol. 1992;10(4):257-9.

Murhekar MV, Murhekar KM, Sehgal SC. Alarming prevalence of hepatitis-B infection among the Jarawas: a primitive Negrito tribe of Andaman & Nicobar Islands, India. J Viral Hepat. 2003;10(3):232-3.

Singh S, Prasad R, Mohanty A. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district Jail in Northern India. Int J STD AIDS. 1999;10(7):475-8.

Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci. 2005;2:36-40.

Changotra H, Dwivedi A, Nayyar AK, Sehajpal PK. Diagnosing different stages of hepatitis B infection using a competitive polymerase chain reaction assay. Indian J Med Microbiol. 2008;26(2):138-42.

Funk ML, Rosenberg DM, Lok ASF. World-wide epidemiology of HBeAg- negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat. 2002;9:52-61.

Bortolotti F, Cadrobbi P, Crivellaro C. Long term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology. 1990;99:805-10.